Procollagen-Like Protein as a Molecular Target in the Treatment of Primary Brain Tumor
Author(s) -
Medhi Wangpaichitr,
Howard J. Landy,
Chun Wu,
Lynn G. Feun,
Rong Xu,
Jenny Xu,
Niramol Savaraj
Publication year - 2002
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2002.59
Subject(s) - brain tumor , procollagen peptidase , primary (astronomy) , medicine , cancer research , bioinformatics , pathology , biology , physics , astronomy
METHODS. cDNA library was obtained in one glioma cell line which highly expressed this protein and screening was performed using VDR monoclonal antibody. This partial cDNA was then subcloned into pcDNA3.1 and sequencing was performed. This partial cDNA sequence also was used as a probe to identify mRNA, which encodes for this putative gene. To characterize this 220-Kd protein, we have used five cell lines as follows: Glioma 1, U118, SW1783, which possess variable amount of 220-Kd protein, and U-373 and T-98G which lack this 220-Kd protein.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom